Last reviewed · How we verify
NCT03245502
The Effect of Blood Transfusion on Venoarterial PCO2 Difference in Cardiac Surgery
trial testing Blood transfusion in Cardiac Procedure Complication in 127 participants. Completed in 1 December 2017.
1 November 2017
Quick facts
| Lead sponsor | Turkiye Yuksek Ihtisas Education and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 127 |
| Start date | 20 August 2017 |
| Primary completion | 1 November 2017 |
| Estimated completion | 1 December 2017 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Blood transfusion — full drug profile →
Conditions studied
- Cardiac Procedure Complication — all drugs for Cardiac Procedure Complication →
Sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital
Who can join
Adults 18 to 75, any sex, with Cardiac Procedure Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Venoarterial CO2 difference(delta PCO2), lactate, central venous oxygen saturation(ScVO2) will be recorded in several steps in coronary artery bypass graft and valvular cardiac operations. The patients will be divided into two groups as Transfused, and Non-Transfused Groups observationally. The trend of delta CO2, lactate, ScVO2, postoperative creatinine values, postoperative complications and 28 days mortality will be compared.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of dilutional anemia that can be treated with only one unit of red blood cell transfusion on tissue oxygenation in cardiac surgery patients
Tezcan, Bölükbaşı D, Şaylan A, Turan S, et al · · 2019 · cited 4× · PMID 31408294 · DOI 10.3906/sag-1901-213
Verify or expand the search:
- PubMed search for NCT03245502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood transfusion
Trials testing the same drug.
- NCT06285604 — Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia · active not recruiting
- NCT04866953 — UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes · completed
- NCT05590429 — Blood Transfusion in Patients With Lung Cancer · unknown
- NCT04537221 — Nordic Cystectomy Study III - Transfusion · unknown
- NCT03930355 — Perioperative Transfusion Related Outcome · completed
Other Turkiye Yuksek Ihtisas Education and Research Hospital trials
Trials by the same sponsor.
- NCT05264987 — Outcomes of Obstetric Patients With COVID-19 Disease in the ICU · completed
- NCT04691934 — Obstetric Anesthesia Experiences in COVID-19 Positive Patients · completed
- NCT04828408 — Diaphragm Functions in Bariatric Surgeries · completed
- NCT04816344 — Emergence Delirium in Children for Magnetic Resonance Imaging · completed
- NCT04828967 — Use of Hypnosis in Hyperemesis Gravidarum · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03245502 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turkiye Yuksek Ihtisas Education and Research Hospital
- Last refreshed: 18 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03245502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing